- Report
- January 2026
- 185 Pages
Global
From €3220EUR$3,545USD£2,780GBP
€3578EUR$3,939USD£3,089GBP
- Report
- September 2025
- 142 Pages
Global
From €3500EUR$4,127USD£3,127GBP
- Report
- October 2025
- 456 Pages
Global
From €4497EUR$4,950USD£3,882GBP
- Report
- January 2026
- 187 Pages
Global
From €3220EUR$3,545USD£2,780GBP
€3578EUR$3,939USD£3,089GBP
- Report
- August 2025
- 193 Pages
Global
From €3220EUR$3,545USD£2,780GBP
€3578EUR$3,939USD£3,089GBP
- Report
- August 2025
- 180 Pages
Global
From €3220EUR$3,545USD£2,780GBP
€3578EUR$3,939USD£3,089GBP
- Report
- August 2025
- 192 Pages
Global
From €3220EUR$3,545USD£2,780GBP
€3578EUR$3,939USD£3,089GBP
- Report
- February 2026
- 250 Pages
Global
From €4079EUR$4,490USD£3,521GBP
- Report
- February 2026
- 250 Pages
Global
From €4079EUR$4,490USD£3,521GBP
- Report
- June 2026
- 362 Pages
Global
From €5314EUR$5,850USD£4,588GBP
- Report
- June 2026
- 478 Pages
Global
From €5314EUR$5,850USD£4,588GBP
- Report
- August 2025
- 190 Pages
Global
From €3220EUR$3,545USD£2,780GBP
€3578EUR$3,939USD£3,089GBP
- Report
- June 2026
- 381 Pages
Global
From €5314EUR$5,850USD£4,588GBP
- Drug Pipelines
- April 2026
- 280 Pages
Global
From €2725EUR$3,000USD£2,353GBP
- Report
- December 2025
- 150 Pages
Global
From €4406EUR$4,850USD£3,804GBP
- Report
- August 2025
- 150 Pages
Global
From €4406EUR$4,850USD£3,804GBP
- Report
- February 2026
- 160 Pages
Global
From €3770EUR$4,150USD£3,255GBP
- Report
- June 2025
- 89 Pages
North America
From €3134EUR$3,450USD£2,706GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3270EUR$3,600USD£2,823GBP
- Report
- August 2023
- 336 Pages
Global
From €4224EUR$4,650USD£3,647GBP

The Type 2 Diabetes Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat Type 2 Diabetes, a chronic condition in which the body does not produce enough insulin or is unable to use insulin properly. Type 2 Diabetes Drugs are used to help control blood sugar levels, reduce the risk of complications, and improve overall health. These drugs can be taken orally, injected, or inhaled. Common Type 2 Diabetes Drugs include Metformin, Sulfonylureas, Thiazolidinediones, Meglitinides, DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors.
Some companies in the Type 2 Diabetes Drug market include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, Boehringer Ingelheim, and Takeda. Show Less Read more